{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:23:36Z","timestamp":1787315016865,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003725","name":"Korea National Research Foundation","doi-asserted-by":"crossref","award":["NRF-2021R1A2C100448711"],"award-info":[{"award-number":["NRF-2021R1A2C100448711"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Government-wide R&D to Advance Infectious Disease Prevention and Control","award":["HG23C1629"],"award-info":[{"award-number":["HG23C1629"]}]},{"name":"US NSF Center for Analysis and Prediction of Pandemic Expansion","award":["DBI 2412115"],"award-info":[{"award-number":["DBI 2412115"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Health Econ Health Policy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s40258-026-01056-0","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T16:05:32Z","timestamp":1785254732000},"page":"869-882","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cost-Effectiveness of Adult Hepatitis A Vaccination Strategies in Korea Under an Aging Susceptibility Profile"],"prefix":"10.1007","volume":"24","author":[{"given":"Yuna","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Chowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7411-3134","authenticated-orcid":false,"given":"Eunok","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"1056_CR1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.clinmicnews.2020.10.001","volume":"42","author":"GW Webb","year":"2020","unstructured":"Webb GW, Kelly S, Dalton HR. Hepatitis A and hepatitis E: clinical and epidemiological features, diagnosis, treatment, and prevention. Clin Microbiol Newsl. 2020;42:171\u20139. https:\/\/doi.org\/10.1016\/j.clinmicnews.2020.10.001.","journal-title":"Clin Microbiol Newsl"},{"key":"1056_CR2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S0891-5520(05)70123-9","volume":"14","author":"NM Kemmer","year":"2000","unstructured":"Kemmer NM, Miskovsky EP. HEPATITIS A. Infect Dis Clin North Am Elsevier. 2000;14:605\u201315. https:\/\/doi.org\/10.1016\/S0891-5520(05)70123-9.","journal-title":"Infect Dis Clin North Am. Elsevier"},{"key":"1056_CR3","unstructured":"The Korean Association for the study of the Liver. White Paper on Liver Diseases in Korea [Internet]. Korea; 2023. https:\/\/www.kasl.org\/bbs\/?number=5499&mode=view&code=ency&keyfield=&keyword=&category=&gubun=&orderfield=. Accessed 19 Sep 2024"},{"key":"1056_CR4","unstructured":"Korea Disease Control and Prevention Agency. Infectious Disease Portal: Major statistics by sex and age, hepatitis A [Internet]. Korea Disease Control and Prevention Agency. [cited 2026 Jun 18]. https:\/\/dportal.kdca.go.kr\/pot\/is\/inftnsdsEDW.do. Accessed 18 Jun 2026."},{"key":"1056_CR5","doi-asserted-by":"publisher","DOI":"10.4178\/epih.e2019038","volume":"41","author":"M Ki","year":"2019","unstructured":"Ki M, Son H, Choi BY. Causes and countermeasures for repeated outbreaks of hepatitis A among adults in Korea. Epidemiol Health. 2019;41:e2019038. https:\/\/doi.org\/10.4178\/epih.e2019038.","journal-title":"Epidemiol Health"},{"key":"1056_CR6","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jval.2015.02.004","volume":"18","author":"P Dhankhar","year":"2015","unstructured":"Dhankhar P, Nwankwo C, Pillsbury M, Lauschke A, Goveia MG, Acosta CJ, et al. Public Health Impact and Cost-Effectiveness of Hepatitis A Vaccination in the United States: A Disease Transmission Dynamic Modeling Approach. Value in Health. 2015;18:358\u201367. https:\/\/doi.org\/10.1016\/j.jval.2015.02.004.","journal-title":"Value in Health."},{"key":"1056_CR7","doi-asserted-by":"publisher","first-page":"6315","DOI":"10.1016\/j.vaccine.2021.08.087","volume":"39","author":"EH Elbasha","year":"2021","unstructured":"Elbasha EH, Choi Y, Daniels V, Goveia MG. Cost-effectiveness of routine catch-up hepatitis A vaccination in the United States: dynamic transmission modeling study. Vaccine. 2021;39:6315\u201321. https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.087.","journal-title":"Vaccine"},{"key":"1056_CR8","unstructured":"Korea Centers for Disease Control and Prevention. Economic Analysis of Vaccination and Development of Guidelines for Control of Hepatitis A Virus Infection, and Epidemiologic Analysis and Development of Control Strategy of Hepatitis C Virus Infection [Internet]. 2009 Dec. https:\/\/scienceon.kisti.re.kr\/srch\/selectPORSrchReport.do?cn=TRKO201300000564#; Accessed 29 Dec 2025."},{"key":"1056_CR9","unstructured":"Lim Y, Seo Y, Lee J, Jung E. Comparison of the effectiveness and costs of hepatitis A vaccination strategies to mitigate future deaths in the Republic of Korea [Internet]. 2025. https:\/\/arxiv.org\/abs\/2509.05373."},{"key":"1056_CR10","unstructured":"Ministry of Health and Welfare. Korea Health Statistics 2015: Korea National Health and Nutrition Examination Survey (KNHANES VI-3). 2016 Dec."},{"key":"1056_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s11538-026-01648-w","volume":"88","author":"YR Liyanage","year":"2026","unstructured":"Liyanage YR, Saucedo O, Tuncer N, Chowell G. A tutorial on structural identifiability of epidemic models using StructuralIdentifiability.jl. Bull Math Biol. 2026;88:102. https:\/\/doi.org\/10.1007\/s11538-026-01648-w.","journal-title":"Bull Math Biol"},{"key":"1056_CR12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1137\/22M1469067","volume":"7","author":"R Dong","year":"2023","unstructured":"Dong R, Goodbrake C, Harrington HA, Pogudin G. Differential Elimination for Dynamical Models via Projections with Applications to Structural Identifiability. SIAM J Appl Algebr Geom. 2023;7:194\u2013235. https:\/\/doi.org\/10.1137\/22M1469067.","journal-title":"SIAM J Appl Algebr Geom."},{"key":"1056_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1005153","volume":"12","author":"AF Villaverde","year":"2016","unstructured":"Villaverde AF, Barreiro A, Papachristodoulou A. Structural identifiability of dynamic systems biology models. PLoS Comput Biol. 2016;12:e1005153. https:\/\/doi.org\/10.1371\/journal.pcbi.1005153.","journal-title":"PLoS Comput Biol"},{"key":"1056_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.idm.2017.08.001","volume":"2","author":"G Chowell","year":"2017","unstructured":"Chowell G. Fitting dynamic models to epidemic outbreaks with quantified uncertainty: a primer for parameter uncertainty, identifiability, and forecasts. Infect Dis Model. 2017;2:379\u201398. https:\/\/doi.org\/10.1016\/j.idm.2017.08.001.","journal-title":"Infect Dis Model"},{"key":"1056_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jtbi.2016.09.025","volume":"412","author":"S Kim","year":"2017","unstructured":"Kim S, Lee J, Jung E. Mathematical model of transmission dynamics and optimal control strategies for 2009 A\/H1N1 influenza in the Republic of Korea. J Theor Biol. 2017;412:74\u201385. https:\/\/doi.org\/10.1016\/j.jtbi.2016.09.025.","journal-title":"J Theor Biol"},{"key":"1056_CR16","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1051\/cocv\/2010027","volume":"17","author":"G Wachsmuth","year":"2011","unstructured":"Wachsmuth G, Wachsmuth D. Convergence and regularization results for optimal control problems with sparsity functional. ESAIM Control Optim Calc Var. 2011;17:858\u201386. https:\/\/doi.org\/10.1051\/cocv\/2010027.","journal-title":"ESAIM Control Optim Calc Var"},{"key":"1056_CR17","doi-asserted-by":"publisher","first-page":"125959","DOI":"10.1109\/ACCESS.2023.3331382","volume":"11","author":"E Taheri","year":"2023","unstructured":"Taheri E, Li N. L2 norm-based control regularization for solving optimal control problems. IEEE Access. 2023;11:125959. https:\/\/doi.org\/10.1109\/ACCESS.2023.3331382.","journal-title":"IEEE Access"},{"key":"1056_CR18","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.2514\/1.G003382","volume":"41","author":"IM Ross","year":"2018","unstructured":"Ross IM, Gong Q, Karpenko M, Proulx RJ. Scaling and Balancing for High-Performance Computation of Optimal Controls. J Guid Control Dyn. 2018;41:2086\u201397. https:\/\/doi.org\/10.2514\/1.G003382.","journal-title":"J Guid Control Dyn"},{"key":"1056_CR19","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511804441","volume-title":"Convex optimization","author":"S Boyd","year":"2004","unstructured":"Boyd S, Vandenberghe L. Convex optimization. Cambridge: Cambridge University Press; 2004."},{"key":"1056_CR20","unstructured":"Ministry of Data and Statistics. Life Table [Internet]. 2024 Dec. https:\/\/mods.go.kr\/board.es?mid=a10301060900&bid=208&act=view&list_no=434042. Accessed 29 Dec 2025."},{"key":"1056_CR21","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/S0140-6736(16)30579-7","volume":"388","author":"JD Stanaway","year":"2016","unstructured":"Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T, Abubakar I, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. The Lancet. 2016;388:1081\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(16)30579-7.","journal-title":"The Lancet"},{"key":"1056_CR22","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"AJ Ferrari","year":"1990","unstructured":"Ferrari AJ, Santomauro DF, Aali A, Abate YH, Abbafati C, Abbastabar H, et al. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 1990;403:2133\u201361. https:\/\/doi.org\/10.1016\/S0140-6736(24)00757-8.","journal-title":"Lancet"},{"key":"1056_CR23","unstructured":"World Health Organization. WHO methods and data sources for global burden of disease estimates 2000-2021 [Internet]. 2024. https:\/\/cdn.who.int\/media\/docs\/default-source\/gho-documents\/global-health-estimates\/ghe2021_daly_methods.pdf. Accessed 23 Apr 2026."},{"key":"1056_CR24","unstructured":"Health Insurance Review & Assessment Service (HIRA). Guidelines for Economic Evaluation of Pharmaceuticals [Internet]. Wonju; 2021 Jan. https:\/\/www.hira.or.kr\/bbsDummy.do?pgmid=HIRAA020002000100&brdScnBltNo=4&brdBltNo=8661. Accessed 21 Apr 2026."},{"key":"1056_CR25","unstructured":"Ministry of Employment and Labor. Wages and working conditions by size, education level, age group, and gender (since 2009) [Internet]. [cited 2025 Dec 29]. https:\/\/kosis.kr\/statHtml\/statHtml.do?orgId=118&tblId=DT_118N_PAY0004. Accessed 29 Dec 2025."},{"key":"1056_CR26","unstructured":"Ministry of Data and Statistics. Total economically active population by age [Internet]. 2025 Dec. https:\/\/kosis.kr\/statHtml\/statHtml.do?orgId=101&tblId=DT_1DA7002S. Accessed 29 Dec 2025."},{"key":"1056_CR27","unstructured":"Ministry of Data and Statistics. Consumer price index by expenditure purpose [Internet]. 2025 [cited 2025 Dec 29]. https:\/\/kosis.kr\/statHtml\/statHtml.do?orgId=101&tblId=DT_1J22001. Accessed 29 Dec 2025."},{"key":"1056_CR28","unstructured":"National Health Insurance Service. Health Insurance Patient Medical Expense Survey [Internet]. 2023. https:\/\/www.nhis.or.kr\/nhis\/together\/wbhaec08200m01.do?mode=view&articleNo=10848682. Accessed 29 Dec 2025."},{"key":"1056_CR29","unstructured":"Health Insurance Review and Assessment Service. National Diseases of Interest Statistics [Internet]. [cited 2025 Dec 29]. https:\/\/opendata.hira.or.kr\/op\/opc\/olapMfrnIntrsIlnsInfoTab1.do. Accessed 29 Dec 2025."},{"key":"1056_CR30","unstructured":"Ministry of Health and Welfare. Daily caregiving costs reduced by KRW 90,000 through strengthened integrated nursing and caregiving services [Internet]. Ministry of Health and Welfare. 2024 [cited 2026 May 1]. https:\/\/www.mohw.go.kr\/board.es?act=view&bid=0027&list_no=1479678&mid=a10503010000&nPage=129&tag=&. Accessed 1 May 2026."},{"key":"1056_CR31","unstructured":"Health Insurance Review & Assessment Service. Cost-effectiveness evaluation results (ICER) for drugs submitted for economic evaluation disclosed for the first time after introduction of the positive list system (Korean) [Internet]. 2022 [cited 2026 Jan 7]. https:\/\/www.hira.or.kr\/bbsDummy.do?brdBltNo=10774&brdScnBltNo=4&pgmid=HIRAA020041000100. Accessed 7 Jan 2026."},{"key":"1056_CR32","doi-asserted-by":"publisher","first-page":"S104","DOI":"10.1016\/j.jval.2011.11.026","volume":"15","author":"E-Y Yim","year":"2012","unstructured":"Yim E-Y, Lim SH, Oh M-J, Park HK, Gong J-R, Park SE, et al. Assessment of Pharmacoeconomic Evaluations Submitted for Reimbursement in Korea. Value in Health. 2012;15:S104\u201310. https:\/\/doi.org\/10.1016\/j.jval.2011.11.026.","journal-title":"Value in Health."},{"key":"1056_CR33","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s10198-021-01426-6","volume":"23","author":"D Husereau","year":"2022","unstructured":"Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, et al. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. Eur J Health Econ. 2022;23:1309\u201317. https:\/\/doi.org\/10.1007\/s10198-021-01426-6.","journal-title":"Eur J Health Econ"},{"key":"1056_CR34","doi-asserted-by":"publisher","first-page":"925","DOI":"10.2471\/BLT.15.164418","volume":"94","author":"MY Bertram","year":"2016","unstructured":"Bertram MY, Lauer JA, De Joncheere K, Edejer T, Hutubessy R, Kieny M-P, et al. Cost-effectiveness thresholds: pros and cons. Bull World Health Organ. 2016;94:925\u201330. https:\/\/doi.org\/10.2471\/BLT.15.164418.","journal-title":"Bull World Health Organ"},{"key":"1056_CR35","doi-asserted-by":"publisher","first-page":"176","DOI":"10.12688\/gatesopenres.13201.1","volume":"4","author":"Y-L Chi","year":"2020","unstructured":"Chi Y-L, Blecher M, Chalkidou K, Culyer A, Claxton K, Edoka I, et al. What next after GDP-based cost-effectiveness thresholds? Gates Open Res. 2020;4:176. https:\/\/doi.org\/10.12688\/gatesopenres.13201.1.","journal-title":"Gates Open Res"},{"key":"1056_CR36","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.131230.2","volume":"12","author":"T Drake","year":"2023","unstructured":"Drake T, Chi Y-L, Morton A, Pitt C. Why cost-effectiveness thresholds for global health donors should differ from thresholds for ministries of health (and why it matters). F1000Res. 2023;12:214. https:\/\/doi.org\/10.12688\/f1000research.131230.2.","journal-title":"F1000Res"},{"key":"1056_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0306293","volume":"19","author":"YK Gurav","year":"2024","unstructured":"Gurav YK, Bagepally BS, Chitpim N, Sobhonslidsuk A, Gupte MD, Chaikledkaew U, et al. Cost-effective analysis of hepatitis A vaccination in Kerala state. India PLoS One. 2024;19:e0306293. https:\/\/doi.org\/10.1371\/journal.pone.0306293.","journal-title":"India. PLoS One."},{"key":"1056_CR38","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1001\/archpedi.154.8.763","volume":"154","author":"RJ Jacobs","year":"2000","unstructured":"Jacobs RJ, Margolis HS, Coleman PJ. The Cost-effectiveness of Adolescent Hepatitis A Vaccination in States With the Highest Disease Rates. Arch Pediatr Adolesc Med. 2000;154:763. https:\/\/doi.org\/10.1001\/archpedi.154.8.763.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"1056_CR39","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.1016\/j.vaccine.2005.03.021","volume":"23","author":"MT Valenzuela","year":"2005","unstructured":"Valenzuela MT, Jacobs RJ, Arteaga O, Navarrete MS, Meyerhoff AS, Innis BL. Cost-effectiveness of universal childhood hepatitis A vaccination in Chile. Vaccine. 2005;23:4110\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2005.03.021.","journal-title":"Vaccine"},{"key":"1056_CR40","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1053\/jhep.2000.16179","volume":"32","author":"R Aycock","year":"2000","unstructured":"Aycock R. Cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C. Hepatology. 2000;32:873. https:\/\/doi.org\/10.1053\/jhep.2000.16179.","journal-title":"Hepatology"},{"key":"1056_CR41","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.vaccine.2019.01.070","volume":"37","author":"LC Ramsay","year":"2019","unstructured":"Ramsay LC, Anyiwe K, Li M, Macdonald L, Coyte PC, Sander B. Economic evaluation of a publicly funded hepatitis A travel vaccination program in Ontario, Canada. Vaccine. 2019;37:1467\u201375. https:\/\/doi.org\/10.1016\/j.vaccine.2019.01.070.","journal-title":"Vaccine"},{"key":"1056_CR42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1023\/A:1022241317979","volume":"3","author":"RJ Jacobs","year":"1999","unstructured":"Jacobs RJ, Meyerhoff AS. Vaccination of sexually active homosexual men against hepatitis A: analysis of costs and benefits. J Gay Lesbian Med Assoc. 1999;3:51\u20138. https:\/\/doi.org\/10.1023\/A:1022241317979.","journal-title":"J Gay Lesbian Med Assoc"}],"container-title":["Applied Health Economics and Health Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-026-01056-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40258-026-01056-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-026-01056-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:34:48Z","timestamp":1787312088000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40258-026-01056-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1056"],"URL":"https:\/\/doi.org\/10.1007\/s40258-026-01056-0","relation":{},"ISSN":["1175-5652","1179-1896"],"issn-type":[{"value":"1175-5652","type":"print"},{"value":"1179-1896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"23 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This study used aggregated surveillance data and secondary data sources and did not involve individual-level information.","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. Patients and the public were not involved in the design, conduct, or reporting of this study.","order":2,"name":"Ethics","label":"Patient and Public Involvement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data sources used in this study are publicly available through the Korea Disease Control and Prevention Agency (KDCA).","order":4,"name":"Ethics","label":"Data Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Model and economic evaluation code is available from the corresponding author upon reasonable request.","order":5,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Conceptualization:\n                      Yuna Lim, Gerardo Chowell, Eunok Jung.\n                      Formal analysis:\n                      Yuna Lim, Gerardo Chowell, Eunok Jung.\n                      Funding acquisition:\n                      Eunok Jung, Gerardo Chowell.\n                      Investigation:\n                      Yuna Lim, Gerardo Chowell, Eunok Jung.\n                      Methodology:\n                      Yuna Lim.\n                      Project administration:\n                      Eunok Jung.\n                      Software:\n                      Yuna Lim.\n                      Supervision:\n                      Eunok Jung.\n                      Validation:\n                      Yuna Lim, Gerardo Chowell.\n                      Visualization:\n                      Yuna Lim.\n                      Writing \u2013 original draft:\n                      Yuna Lim.\n                      Writing \u2013 review & editing:\n                      Yuna Lim, Gerardo Chowell, Eunok Jung.","order":6,"name":"Ethics","label":"Author Contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}